Join date: Jul 8, 2020
Sep 28, 2022 ∙ 3 min
Aqualung Therapeutics Receives FDA Clearance of its IND for Acute Respiratory Distress Syndrome
Aqualung is an early-stage biotech company developing immune-focused therapeutic platform, eNamptor™.
Sep 27, 2022 ∙ 2 min
SeraNovo and Ildong Pharmaceutical to Collaborate on Multi-Compound Research Projects
Our team is addressing two core issues with our proprietary technology: enhancing bioavailability and reducing development time.